Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 43, Issue 4, 2014, Pages 265-272

  Meyfroidt, S ^a   Van Hulst, L ^b   De Cock, D ^a   Van Der Elst, K ^a,c   Joly, J ^c   Westhovens, R ^a,c   Hulscher, M ^b   Verschueren, P ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; DRUG EFFICACY; FEAR; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HUMAN; MALE; MEDICAL STAFF; MULTICENTER STUDY (TOPIC); NURSE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; RHEUMATOLOGY; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; HEALTH CARE PERSONNEL; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 84905450350     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.863382     Document Type: Article

References (46)

1. Tobon GJ, Youinou P, Saraux A. The environment, geoepidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010;35:10-14.
2. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010; 69:964-75.
3. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012;64:625-39.
4. Rheumatoid arthritis: themanagement of rheumatoid arthritis in adults. National Institute for Health and Clinical Excellence (NICE) Clinical guideline CG79 (www.nice.org.uk/CG79). London: NICE, 2009.
5. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological diseasemodifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2013 Oct 25. doi: 10.1136/annrheumdis-2013-204573. [Epub ahead of print]
6. Verschueren P, Esselens G,Westhovens R. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis. Rheumatology 2008;47:59-64.
7. Goekoop-Ruiterman Y, De Vries-Bouwstra J, Allaart C, Van Zeben D, Kerstens P, Hazes J, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
8. Verhoeven A, Bibo J, Boers M, Engel G, Van Der Linden S. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatode Artritis. Rheumatology 1998;37:1102-9.
9. Korthals-de Bos I, Van Tulder M, Boers M, Verhoeven AC, Adr HJ, Bibo J, et al. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. J Rheumatol 2004;31:1709-16.
10. Verschueren P, Westhovens R. Optimal care for early RA patients: the challenge of translating scientific data into clinical practice. Rheumatology 2011;50:1194-200.
11. Garrood T, Shattles W, Scott DL. Treating early rheumatoid arthritis intensively: current UK practice does not reflect guidelines. Clin Rheumatol 2011;30:103-6.
12. Kiely P, Walsh D, Williams R, Young A. Outcome in rheumatoid arthritis patients with continued conventional therapy for moderate disease activity - the early RA network (ERAN). Rheumatology 2011;50:926-31.
13. Esselens G, Westhovens R, Verschueren P. Effectiveness of an integrated outpatient care programme compared with present-day standard care in early rheumatoid arthritis. Musculoskeletal Care 2009;7:1-16.
14. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:iii-iv, 1-72.
15. Grol R, Wensing M, Eccles M. Improving patient care: the implementation of change in clinical practice. Edinburgh: Elsevier Butterworth Heinemann, 2005.
16. Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2005;3:CD005470.
17. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:1225-30.
18. Davis DA, Taylor-Vaisey A. Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Can Med Assoc J 1997;157:408-16.
19. Francke AL, Smit MC, De Veer AJE, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 2008;8:38.
20. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PAC, et al. Why don't physicians follow clinical practice guidelines? J Am Med Assoc 1999;282:1458-65.
21. van Tuyl LHD, Plass AMC, Lems WF, Voskuyl AE, Dijkmans BAC, Boers M. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis? Ann Rheum Dis 2007;66:974-6.
22. Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, et al. What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health 2010;25:1229-45.
23. van Hulst LTC, Hulscher MEJL, van Riel PLCM. Achieving tight control in rheumatoid arthritis. Rheumatology 2011;50:1729-31.
24. Dierckx de Casterle B, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud 2011,49: 360-71.
25. van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Kerstens PJ, Dijkmans BA, et al. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis. Rheumatology 2008;47:1571-6.
26. Jobanputra P, Wilson J, Douglas K, Burls A. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheumatology 2004;43:206-10.
27. Erkan D, Yazici Y, Harrison MJ, Paget SA. Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy. Arthritis Care Res 2002;47:285-90.
28. Mayer J, Piterman L. The attitudes of Australian GPs to evidence-based medicine: a focus group study. Fam Pract 1999;16:627-32.
29. Hadley JA, Wall D, Khan KS. Learning needs analysis to guide teaching evidence-based medicine: knowledge and beliefs amongst trainees from various specialities. BMC Med Educ 2007;7:11.
30. Hay MC, Weisner TS, Subramanian S, Duan N, Niedzinski EJ, Kravitz RL. Harnessing experience: exploring the gap between evidence-based medicine and clinical practice. J Eval Clin Pract 2008;14:707-13.
31. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med 2001;135: 825-34.
32. Cavazos JM, Naik AD,Woofter A, AbrahamNS. Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative study. Aliment Pharmacol Ther 2008; 28:789-98.
33. Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. Br Med J 2001 323 1100-2.
34. Bradley CP. Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners. Br J Gen Pract 1992;42:454-8.
35. Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, et al. Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med 2009;24:218-25.
36. Howes F, Hansen E, Williams D, Nelson M, Barriers to diagnosing and managing hypertension. Aust Fam Physician 2010;39:511-16.
37. Ab E, Denig P, van Vliet T, Dekker JH. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Fam Pract 2009;10:24.
38. Durack-Bown I, Giral P, d'Ivernois JF, Bazin C, Chadarevian R, Benkritly A, et al. Patients' and physicians' perceptions and experience of hypercholesterolaemia: a qualitative study. Br J Gen Pract 2003;53:851-7.
39. Westhovens R, Boonen A, Verbruggen L, Durez P, De Clerck L, Malaise M, et al. Healthcare consumption and direct costs of rheumatoid arthritis in Belgium. Clin Rheumatol 2005;24:615-19.
40. Shrank WH, Joseph GI, Choudhry NK, Young HN, Ettner SL, Glassman P, et al. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Am J Manag Care 2006;12:545-51.
41. Kimchi J, Polivka B, Stevenson JS. Triangulation: operational definitions. Nurs Res 1991;40:364-6.
42. Grol R, Grimshaw J. Evidence-based implementation of evidencebased medicine. Jt Comm J Qual Improv 1999;25:503-13.
43. Elwyn G, Edwards A, Mowle S, Wensing M, Wilkinson C, Kinnersley P, et al. Measuring the involvement of patients in shared decision-making: a systematic review of instruments. Patient Educ Couns 2001;43:5-22.
44. Bekkering GE, Engers AJ, Wensing M, Hendriks HJ, van Tulder MW, Oostendorp RA, et al. Development of an implementation strategy for physiotherapy guidelines on low back pain. Aust J Physiother 2003;49:208-14.
45. Carlfjord S, Lindberg M, Bendtsen P, Nilsen P, Andersson A. Key factors influencing adoption of an innovation in primary health care: a qualitative study based on implementation theory. BMC Fam Pract 2010;11:60.
46. Donnan GA. PROGRESS results: implementation in stroke guidelines. J Hypertens Suppl 2003;21:S25-8.